Trupanion (NASDAQ:TRUP – Free Report) had its price target trimmed by Cantor Fitzgerald from $42.00 to $34.00 in a research report released on Thursday morning,Benzinga reports. The firm currently has a neutral rating on the financial services provider’s stock.
A number of other equities research analysts have also recently issued reports on the company. Weiss Ratings cut Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 4th. Piper Sandler dropped their price objective on Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Stifel Nicolaus decreased their target price on Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Finally, Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $42.50.
View Our Latest Stock Analysis on Trupanion
Trupanion Trading Up 0.3%
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The company had revenue of $376.85 million for the quarter, compared to the consensus estimate of $375.89 million. During the same quarter in the prior year, the company earned $0.04 EPS. The company’s revenue for the quarter was up 11.7% on a year-over-year basis. Equities research analysts predict that Trupanion will post 0.13 earnings per share for the current fiscal year.
Insider Buying and Selling at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 2,837 shares of the firm’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $26.46, for a total transaction of $75,067.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CRO Emily Dreyer sold 7,792 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $28.15, for a total value of $219,344.80. Following the sale, the executive directly owned 35,627 shares of the company’s stock, valued at $1,002,900.05. This represents a 17.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 21,502 shares of company stock valued at $580,315 in the last quarter. 5.42% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRUP. Millennium Management LLC grew its holdings in Trupanion by 185.8% in the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after buying an additional 402,421 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Trupanion by 116.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock valued at $17,826,000 after buying an additional 256,559 shares in the last quarter. Two Sigma Investments LP grew its holdings in Trupanion by 3,201.0% in the 3rd quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock valued at $9,713,000 after buying an additional 217,634 shares in the last quarter. Polar Capital Holdings Plc grew its holdings in Trupanion by 13.5% in the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock valued at $55,121,000 after buying an additional 175,000 shares in the last quarter. Finally, Marshall Wace LLP grew its holdings in Trupanion by 15.5% in the 3rd quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock valued at $52,462,000 after buying an additional 163,101 shares in the last quarter.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Articles
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
